CEO Edward Pershing Lifts Stake to 11.61% Through Ongoing Note Conversions
PVCT sits 51% above its 52-week low of $0.038 on elevated volume (2.0× avg).
Summary
CEO Edward Pershing's beneficial ownership reached 11.61% after converting $235,000 in notes and buying a new $15,000 note, with $908,554 in notes still convertible.
Key Events · Ownership and Investor Activity · PVCT
-
CEO Stake Increases to 11.61%
Chairman and CEO Edward Pershing now beneficially owns 52,441,275 shares, representing 11.61% of the outstanding total, up from prior levels due to recent note conversions and purchases.
-
$235K in Notes Converted in 60 Days
Between May 7 and June 5, 2026, $235,000 principal amount of convertible notes automatically converted into 92,490 shares of Series D-1 preferred stock, which are convertible into 924,900 common shares.
-
New $15K Note Purchase Under 2025 Financing
On May 28, 2026, Pershing purchased a $15,000 convertible note from the company, adding to his existing $908,554 in remaining notes that can convert into 3.6 million common shares.
-
Remaining Conversion Potential
Pershing holds $908,554 in convertible notes plus accrued interest, convertible into 363,314 Series D-1 preferred shares, which would yield 3,633,141 common shares upon conversion.
Analysis · PVCT · Life Sciences
Chairman and CEO Edward Pershing now beneficially owns 52.4 million shares, or 11.61% of Provectus, up from prior filings. The increase stems from automatic conversions of $235,000 in convertible notes into Series D-1 preferred stock over the past 60 days, plus a new $15,000 note purchase. Pershing still holds $908,554 in remaining notes that can convert into another 3.6 million common shares. This insider accumulation signals continued personal financial commitment as the company faces a critical cash position and prepares for a reverse stock split.
At the time of this filing, PVCT was trading at $0.06 on OTC in the Life Sciences sector, with a market capitalization of approximately $24.2M. The 52-week trading range was $0.04 to $0.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.